CN Stock MarketDetailed Quotes

688136 Kexing Biopharm

Watchlist

17.90
+0.02+0.11%

Market Closed Dec 13 15:00 CST

3.57BMarket Cap-30.08P/E (TTM)

Kexing Biopharm Stock Forum

Moomoo AI

Feb 1 18:42

The market anticipates continued poor revenue growth, possibly suppressing the P/S ratio. The company's projected growth is below industry average, potentially causing shareholder pessimism and a depressed P/S. A change in fortune is needed for the P/S to rise.